Hiroki Yano

Specific Recruitment of CC Chemokine Receptor 4–Positive Regulatory T Cells in Hodgkin Lymphoma Fosters Immune Privilege

Takashi Ishida, Toshihiko Ishii, Atsushi Inagaki et al. · Cancer Research · 2006 · 287 citations · Full text

Defucosylated Humanized Anti-CCR4 Monoclonal Antibody KW-0761 as a Novel Immunotherapeutic Agent for Adult T-cell Leukemia/Lymphoma

Toshihiko Ishii, Takashi Ishida, Atae Utsunomiya et al. · Clinical Cancer Research · 2010 · 243 citations

N,N-Dimethylformamide-stabilized gold nanoclusters as a catalyst for the reduction of 4-nitrophenol

Hiroko Yamamoto, Hiroki Yano, Haruki Kouchi et al. · Nanoscale · 2012 · 209 citations

Engineering, Nanocluster, Metal Nanoparticles +16

Defucosylated anti-CCR4 monoclonal antibody exercises potent ADCC-mediated antitumor effect in the novel tumor-bearing humanized NOD/Shi-scid, IL-2Rγnull mouse model

Asahi Ito, Takashi Ishida, Hiroki Yano et al. · Cancer Immunology Immunotherapy · 2008 · 126 citations · Full text

Pituitary-Directed Leukemia Inhibitory Factor Transgene Causes Cushing’s Syndrome: Neuro-Immune-Endocrine Modulation of Pituitary Development

Hiroki Yano, Carol Readhead, Masahiro Nakashima et al. · Molecular Endocrinology · 1998 · 103 citations

Genetics, Immunology, Immune Regulation +24